Authors have studied the ultrastructure of Ito-cells in percutane needle-biopsy samples of hepatic tissue from 36 patients. In 3 samples no alteration was found, in four only moderate steatosis occurred without fibrosis. In four samples portal, in ten centrilobular and in five periportal fibrosis was detected, while in five samples cirrhosis was pointed out. In the intact liver, Ito-cells occur not only in the spaces of Disse but also in the wall of the central vein. In portal fibrosis Ito-cells were similar in location and structure to those in the non-fibrotic liver. In centrilobular and periportal fibroses as well as in cirrhosis Ito-cells in the fibrotic parenchyma areas were either localized in the accumulated connective tissue or at the border of connective tissue and hepatocytes. These interstitial Ito-cells contained small amount of lipid, abundant dilated rough endoplasmic reticulum filled with a flocculent material, well-developed Golgi-complex and often bundles of 5 nm thick filaments with dense territories. Close to the Ito-cells immature collagen-fibrils and basement membrane-fragments were seen. A close relationship was pointed out between activated Ito-cells and lymphocytes. In parenchyma areas away from fibrotic foci the structure of Ito-cells was comparable to that of Ito-cells in intact hepatic lobules. Observations suggest that Ito-cells are related to fibroblasts and myofibroblasts and play a role in the pathogenesis of fibrosis occurring in human liver diseases.

Download full-text PDF

Source

Publication Analysis

Top Keywords

ito-cells
10
centrilobular periportal
8
parenchyma areas
8
connective tissue
8
[ultrastructure ito
4
ito cells
4
cells fibrotic
4
liver
4
fibrotic liver
4
liver diseases]
4

Similar Publications

Although therapies based on direct-acting antivirals (DAAs) effectively eradicate hepatitis C virus (HCV) in patients, there is still a high risk of liver fibrosis even after a sustained virological response. Therefore, it is of great clinical importance to understand the mechanism of potential factors that promote liver fibrosis after virological cure by treatment with DAAs. Here, we found that tubulointerstitial nephritis antigen-like 1 (TINAGL1) is significantly increased in HCV-infected hepatocytes and in the liver of patients with liver fibrosis, and that higher TINAGL1 expression persists in HCV-eradicated hepatocytes after treatment with DAAs.

View Article and Find Full Text PDF

Targeting p97/Valosin-Containing Protein Promotes Hepatic Stellate Cell Senescence and Mitigates Liver Fibrosis.

DNA Cell Biol

January 2025

Research Center of Integrated Traditional Chinese and Western Medicine, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou 646000, China.

Liver fibrosis, one of the main histological determinants of various chronic liver diseases, currently lacks effective treatment. Hepatic stellate cells (HSCs) are pivotal in the production of extracellular matrix and amplify the fibrogenic response. Inhibiting the activation of HSCs or promoting the senescence of activated HSCs is crucial for the regression of liver fibrosis.

View Article and Find Full Text PDF

Harnessing nature's arsenal: Targeting the TGF-β/Smad Cascade with novel natural anti-fibrotic agents.

Fitoterapia

January 2025

Translational Chinese Medicine Key Laboratory of Sichuan Province, Sichuan Academy of Chinese Medicine Sciences, Sichuan Institute for Translational Chinese Medicine,Chengdu, Sichuan 610041, PR China. Electronic address:

Background: Hepatic fibrosis is a wound healing response that leads to excessive deposition of extracellular matrix (ECM) due to sustained liver injury. Hepatic stellate cells (HSCs) are key players in ECM synthesis, with the TGF-β/Smad signaling pathway being central to their activation. Despite advances in understanding the pathogenesis of hepatic fibrosis, effective anti-fibrotic therapies are still lacking.

View Article and Find Full Text PDF

Myosin light chain 9 mediates graft fibrosis after pediatric liver transplantation through TLR4/MYD88/NF-κB signaling.

Cell Mol Gastroenterol Hepatol

January 2025

Department of Liver Transplantation, Tianjin First Central Hospital, Tianjin, China; Tianjin Key Laboratory of Organ Transplantation, Tianjin First Central Hospital, Tianjin, China. Electronic address:

Background & Aims: The incidence of graft fibrosis is elevated following pediatric liver transplantation (pLT) and is influenced by cold ischemic time (CIT). Myosin light chain 9 (MYL9), a member of the myosin family, could act on hepatic stellate cells (HSCs) and induce a transition to active phase. We hypothesized that cold ischemic injury could stimulate MYL9 expression and lead to graft fibrosis.

View Article and Find Full Text PDF

In this chapter, we present a detailed protocol for establishing a three-dimensional (3D) multicellular tumor spheroids (MCTSs) model to simulate the tumor microenvironment (ME) associated with metabolic dysfunction-associated steatotic liver disease (MASLD) for the study of hepatocellular carcinoma (HCC) and colorectal cancer (CRC) cell aggressiveness, growth, and metastasis potential. The MASLD microenvironment (MASLD-ME) is recreated by embedding hepatic stellate cells in a collagen I matrix within a Boyden chamber system. The metabolic medium mimics MASLD conditions, enriched with high glucose, fructose, insulin, and fatty acids, to simulate metabolic stresses associated with the disease.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!